Literature DB >> 12353846

Temporal changes in colonic vascular architecture and inflammatory mediator levels in animal models of colitis.

Caroline B Appleyard1, Adrian Alvarez, William H Percy.   

Abstract

This study investigated the temporal relationship between inflammatory mediator production and colonic vascular architecture in rabbit and rat trinitrobenzene sulfonic acid (TNBS) models of colitis. In both species significant colonic damage and loss of mucosal integrity occurred over time. In the rabbit there was a significant increase in TxB2 levels in the muscularis propria and mucosa at 1, 6, and 48 hr after TNBS, with a significant elevation in PGE2 production in the muscularis propria at 48 hr. However, elevated mediator levels were not associated with measurable changes in vascular architecture. In contrast, significant changes in the numbers and diameters of colonic blood vessels were observed in the rat, in the absence of significant elevations in TxB2 or PGE2 levels. These data suggest that the role of lipid mediators in acute colitis is species-dependent and, although there are corresponding gross and microscopic changes in both models, these occur through disparate mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353846     DOI: 10.1023/a:1019660526241

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Enhancement of human intestinal mast cell mediator release in active ulcerative colitis.

Authors:  C C Fox; A J Lazenby; W C Moore; J H Yardley; T M Bayless; L M Lichtenstein
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

2.  A comparison in vitro of human and rabbit distal colonic muscle responses to inflammatory mediators.

Authors:  W H Percy; M B Burton; F Fallick; R Burakoff
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

3.  Mucosal arachidonate metabolism and intestinal ischemia-reperfusion injury.

Authors:  M J Mangino; C B Anderson; M K Murphy; E Brunt; J Turk
Journal:  Am J Physiol       Date:  1989-08

4.  The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat.

Authors:  N K Boughton-Smith; J L Wallace; G P Morris; B J Whittle
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

5.  Effects of purified Clostridium difficile toxin A on rabbit distal colon.

Authors:  R Burakoff; L Zhao; A J Celifarco; K L Rose; V Donovan; C Pothoulakis; W H Percy
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

6.  Spasm of gastric muscularis mucosae might play a key role in causing focal mucosal ischemia and ulceration. An experimental study in guinea pigs.

Authors:  C K Piasecki; C Thrasivoulou
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

7.  Exaggerated prostaglandin production by colonic smooth muscle in rabbit colitis.

Authors:  H W Kao; R D Zipser
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

8.  A radioimmunoassay for 6-keto-prostaglandin F1alpha.

Authors:  J A Salmon
Journal:  Prostaglandins       Date:  1978-03

9.  In vitro changes in the properties of rabbit colonic muscularis mucosae in colitis.

Authors:  W H Percy; M B Burton; K Rose; V Donovan; R Burakoff
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

10.  Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs.

Authors:  C B Appleyard; J L Wallace
Journal:  Am J Physiol       Date:  1995-07
View more
  8 in total

1.  Structural adaptations in the murine colon microcirculation associated with hapten-induced inflammation.

Authors:  Dino J Ravnic; Moritz A Konerding; Akira Tsuda; Harold T Huss; Tanja Wolloscheck; Juan P Pratt; Steven J Mentzer
Journal:  Gut       Date:  2006-11-17       Impact factor: 23.059

Review 2.  Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.

Authors:  Livija Deban; Carmen Correale; Stefania Vetrano; Alberto Malesci; Silvio Danese
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

3.  Role of PGE2 in the colonic motility: PGE2 generates and enhances spontaneous contractions of longitudinal smooth muscle in the rat colon.

Authors:  Yumiko Iizuka; Atsukazu Kuwahara; Shin-Ichiro Karaki
Journal:  J Physiol Sci       Date:  2013-10-30       Impact factor: 2.781

4.  Thromboxane-prostanoid receptor expression and antagonism in dextran-sodium sulfate-induced colitis.

Authors:  Patsy R Carter; Robert M McElhatten; Songlin Zhang; William S Wright; Norman R Harris
Journal:  Inflamm Res       Date:  2010-08-08       Impact factor: 4.575

5.  Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.

Authors:  Gabriella Varga; Melinda Ugocsai; Petra Hartmann; Norbert Lajkó; Réka Molnár; Szilárd Szűcs; Dávid Kurszán Jász; Dániel Érces; Miklós Ghyczy; Gábor Tóth; Mihály Boros
Journal:  Inflammopharmacology       Date:  2017-04-27       Impact factor: 4.473

6.  The emerging coloprotective effect of sildenafil against ulcerative colitis in rats via exerting counterbalance between NF-κB signaling and Nrf-2/HO-1 pathway.

Authors:  Ghada S El-Tanbouly; Rehab S Abdelrahman
Journal:  Inflammopharmacology       Date:  2022-07-14       Impact factor: 5.093

7.  Bimodal oscillation frequencies of blood flow in the inflammatory colon microcirculation.

Authors:  Akira Tsuda; Aslihan Turhan; Moritz Konerding; Dino Ravnic; Dusan Hanidziar; Miao Lin; Steven J Mentzer
Journal:  Anat Rec (Hoboken)       Date:  2009-01       Impact factor: 2.064

8.  Infusion of HIV-1 Nef-expressing astrocytes into the rat hippocampus induces enteropathy and interstitial pneumonitis and increases blood-brain-barrier permeability.

Authors:  Jocelyn Rivera; Raymond A Isidro; Raisa Y Loucil-Alicea; Myrella L Cruz; Caroline B Appleyard; Angel A Isidro; Gladys Chompre; Krystal Colon-Rivera; Richard J Noel
Journal:  PLoS One       Date:  2019-11-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.